Republican Lawmakers Want Biden to Reclassify Cannabis

Republican lawmakers are asking President Joe Biden to keep his promise and reschedule cannabis under the Controlled Substances Act. 

Yes, you read the lede right. Republicans are asking Biden, a Democrat, to reschedule weed once and for all. 

Representatives Dave Joyce (R-OH) and Don Young (R-AK) both serve as co-chairs of the Congressional Cannabis Caucus. They recently sent a letter to Biden asking for rescheduling and claiming the issue is “a matter of public health.”

Despite all the work that has been happening at the state level to legalize medical and recreational cannabis, it is still classified federally as a Schedule I drug in the U.S., as most cannabis enthusiasts well know. This puts it in the same category with drugs like heroin that are known to be much more harmful. The classification means that cannabis has no medical value and a high potential for abuse in the country’s eyes. 

“As a Schedule I substance, cannabis is not accepted for medical use on the federal level, which has caused significant research restrictions and continues to thwart the treatment of a wide range of patients, including those suffering from cancer as well as veterans with post-traumatic stress disorder (PTSD) and people living with Multiple Sclerosis and seizure disorders,” the letter explains regarding the status of cannabis. 

Keep reading

Police Are Lying About “No-Knock” Warrants

Police claim they need “no-knock” warrants to pursue murderers and violent criminals. But, this rarely seems to be the case. In reality, no-knock warrants are a tool that law enforcement used to beef up the war on drugs in the 1980s, and cops have continued to use them mainly for that purpose ever since.

No-knock warrants allow police to enter a building without knocking or announcing themselves. This creates an element of surprise. Law enforcement apologists claim boosts officer safety and keeps criminals from destroying evidence. But oftentimes, the reaction of surprised occupants, often awakened from a dead sleep, leads to a violent police response.

That’s what happened to Breonna Taylor.

The 26-year-old woman was in bed with her boyfriend Kenneth Walker in the early-morning hours of March 13 when Louisville police broke into her home executing a no-knock warrant issued earlier that day. Walker claims he heard banging on the door but never hear anybody say “police.” When the officers broke down the door, Walker fired a shot, hitting an officer in the leg. Police returned fire, killing Taylor. She suffered at least eight gunshot wounds.

Taylors death sparked a movement to do away with no-knock warrants. Police insist they need them to catch dangerous criminals. But more often than not, they are employed in run-of-the-mill drug raids, not in pursuit of murders and rapists as police claim.

Let’s take for example the case of Lexington, Kentucky. Currently, the City Council is embroiled in a legal battle with a police union after passing a ban on “no-knock” warrants earlier this year. Fraternal Order of Police attorney Scott Crosbie said police believe the no-knock warrants will keep them safe and that they should remain on the table as a bargaining tool. According to the FOP, Lexington is experiencing a 67 percent increase in homicides, combined with staffing shortages. But what does this have to do with “no-knock” warrants?

The implication seems to be that without the “no-knock” warrants, police will be put in danger as they try to apprehend violent and dangerous criminals such as murderers and rapists. But the Lexington Herald-Leader obtained copies of past no-knock warrants in 2020.  All of the cases were drug-related – no murderers were apprehended.

Keep reading

A Record Number of Drug-Related Deaths Illustrates the Lethal Consequences of Prohibition

The United States saw a record number of drug-related deaths in 2020. The total exceeded 93,000, which was up 29 percent from 2019, according to the latest estimates from the Centers for Disease Control and Prevention (CDC). The 2020 spike—the largest ever recorded—was largely attributable to the COVID-19 pandemic and the legal restrictions it provoked. But drug-related deaths already were rising before anyone had heard of the coronavirus, not just despite but also because of the government’s efforts to prevent people from using psychoactive substances.

The new CDC numbers confirm the folly of relying on supply control measures to reduce drug fatalities. Those policies are based on the premise that drug availability by itself causes drug-related deaths, which is clearly not true in light of the social, economic, and psychological factors that plausibly explain last year’s surge. In any case, attacking production and distribution through legal restrictions, interdiction, seizures, and arrests rarely has a significant or lasting impact on prices or availability. Worse, those interventions drive substitutions that make drug use deadlier, as illustrated by the rise of illicit fentanyl and the crackdown on prescription pain medication, which accelerated the upward trend in opioid-related deaths.

Keep reading

Democrats have a new plan to legalize marijuana federally

On Wednesday, Sens. Cory Booker (D-NJ), Chuck Schumer (D-NY), and Ron Wyden (D-OR) released a discussion draft of legislation that proposes sweeping reform to marijuana policy in the US. The Cannabis Administration and Opportunity Act would decriminalize marijuana federally, expunge federal non-violent cannabis convictions (and encourage states to do the same), and create “new grant programs to fund nonprofits that provide services to those adversely impacted by the War on Drugs.”

In the introduction to the 30-page draft legislation, the senators note that adult use of cannabis is already legal in 18 states, Washington D.C., the Northern Mariana Islands, and Guam. Medicinal marijuana is even more widespread, legal in 37 states, Puerto Rico, D.C., Guam, and the US Virgin Islands.

“These changes represent a dynamic shift in public opinion and support across the political spectrum,” the statement notes. “State-compliant cannabis businesses will finally be treated like other businesses and allowed access to essential financial services, like bank accounts and loans. Medical research will no longer be stifled.”

Despite recent state actions, marijuana remains illegal at the federal level and subject to prosecution by federal agencies even in states where cannabis use is permitted. In practice, those prosecutions have been limited, but the risk of federal action has meant that marijuana businesses have limited options when it came to banking and many non-recreational uses of the plant have been stifled.

Keep reading

Drug overdose deaths in 2020 hit the highest number ever recorded, CDC data shows

Drug overdose deaths rose by close to 30% in the United States in 2020, hitting the highest number ever recorded, the U.S. Centers for Disease Control and Prevention reported Wednesday.

More than 93,000 people died from drug overdoses in 2020, according to provisional data released by the CDC’s National Center for Health Statistics. That’s a 29.4% increase from the 72,151 deaths projected for 2019.

“Overdose deaths from synthetic opioids (primarily fentanyl) and psychostimulants such as methamphetamine also increased in 2020 compared to 2019. Cocaine deaths also increased in 2020, as did deaths from natural and semi-synthetic opioids (such as prescription pain medication),” the NCHS said in a statement.

“This is the highest number of overdose deaths ever recorded in a 12-month period, and the largest increase since at least 1999,” Dr. Nora Volkow, director of the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, said in a statement.

“These data are chilling. The COVID-19 pandemic created a devastating collision of health crises in America,” added Volkow.

As in recent years, inappropriate use of opioids was behind most of the deaths. The NCHS reported that overdose deaths from opioids rose from 50,963 in 2019 to 69,710 in 2020.

Keep reading

Sobriety for dollars: California lawmakers move to pay meth addicts to stay clean

California lawmakers are closer to sending Gov. Gavin Newsom legislation that would offer money for people addicted to methamphetamines to stay in treatment.

Senate Bill 110 would make contingency management, a therapy centered around positive reinforcement, a legal form of treatment in California that would be paid for by Medi-Cal, the state’s Medicaid program.

In the case of people suffering from meth addictions, they would be given incentives to attend treatment or pass drug tests.

Sen. Scott Weiner (D-San Francisco) said in June that President Joe Biden’s administration is seeking evidence-based solutions to the nation’s drug crisis.

Keep reading

If Sha’Carri Richardson Can Get High and Still Outrun Everybody, She Should Be Allowed To Do It

Sha’Carri Richardson ran 100 meters faster than any other woman at the U.S. Olympic trials, but she won’t be able to compete in the event at the Olympic Games in Tokyo after testing positive for marijuana.

There are so, so many things wrong with this. The U.S. Olympic & Paralympic Committee (USOPC) and the U.S. Anti-Doping Agency (USADA), which officially announced Richardson’s month-long suspension on Friday, should be ashamed for how they’ve handled the situation. More importantly, they should change their policies to ensure more athletes aren’t subjected to an unnecessary punishment for using a substance that is obviously not going to provide a competitive edge.

And while the situation seems fairly absurd on its face, it actually gets worse the deeper you go.

Start with the fact that the USADA doesn’t actually classify tetrahydrocannabinol (THC), the psychoactive chemical found in cannabis, as a performance-enhancing drug. But the USADA—whose sole purpose, ostensibly, is to ensure the integrity of athletic events—tests athletes for THC anyway because it regards marijuana as “a ‘Substance of Abuse’ because it is frequently used in society outside the context of sport.”

In the statement announcing Richardson’s suspension, the USADA acknowledged that “Richardson’s…use of cannabis occurred out of competition and was unrelated to sport performance.”

In other words, Richardson’s positive test had no bearing on the fact that she out-raced every other American woman at the Olympic trials—which were held in Eugene, Oregon, where marijuana is legal. Richardson engaged in legal activity that did not bestow upon her an unfair competitive advantage…and yet she’s been suspended anyway.

Keep reading